Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing

Valeant Pharmaceuticals Intl (NYSE: VRX)

Last Updated: Dec-09-2016 19:59:40

Recent Market News

Today's Valeant Pharmaceuticals Stock Update

This Valeant Pharmaceuticals stock price update gives you some of the most important numbers you need to evaluate VRX today, December 10, 2016.First, the most recent closing price of VRX was $15.46. The Valeant Pharmaceuticals stock price went up 0.13% or $0.02 from the day before.Here's how the current Valeant Pharmaceuticals stock price level compares to recent highs and lows...At today's price, VRX is trading at a lower price than it was one-year ago, with shares lower by 83.62%.

TRENDING: The 4 Best Gold Stocks to Buy Now - One's Up 200% in 2016

The Valeant Pharmaceuticals stock price 52-week high is $119.87. That was hit on 12/16/2015. The VRX stock 52-week low is $13.77, reached on 11/08/2016.Also, this - VRX trading volume yesterday was 12,862,500. That's greater than Valeant Pharmaceuticals stock's average daily trading volume of 9,223,064.Valeant Pharmaceuticals's market cap is 5,372,968,000. That gives Valeant Pharmaceuticals a mid-size market cap, because it's been 2 billion and 10 billion. As of the beginning of April, Apple has the biggest market cap of all publicly traded companies.

TRENDING: The Best Stocks in the World Are on Sale Now - We Like These 5

The current P/E (price/earnings) ratio of Valeant Pharmaceuticals stock is 2.24. That's less than the March 2016 S&P 500 P/E ratio of about 23. To really gauge if this stock's P/E is high or low, you should compare VRX to other companies in the same industry.The current EPS (earnings per share) of VRX is -6.43.Beta - how closely the stock trades with the overall market, with a beta of 1 meaning it trades in step with the broader index -- for Valeant Pharmaceuticals is -0.12.Valeant Pharmaceuticals stock does not pay a dividend right now. Most income investors look for "dividend stocks" that have a yield of 2% or more, but there are different factors that affect the health of a company's payout.Every day we publish Valeant Pharmaceuticals stock news and coverage on a handful of other key stocks we're watching now so you can maximize profits. To get new info and stock news on VRX and other companies you are interested in, sign up for Money Morning - it's free.

UP NEXT: This stock is one of the most promising "double" opportunities on the market today - meaning we expect shares to gain 100% from where they are now. The biggest price catalyst is this company is set to dominate virtual reality. Get it's name and a chance to double your money here.

Click here to read more stories

Premium Research

Valeant Pharmaceuticals Intl (NYSE: VRX) Profile

Prior Close$15.44
Market Cap$5.37 B
PE Ratio2.29
Valeant Pharmaceuticals International Inc. is a pharmaceutical company that develops manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology dermatology and branded generics. The Company produces medicines that meet the special health problems of patients. Valeant's development pipeline strategy comprises both new compounds as well as product life cycle management. Its early and late-stage drug candidates have unique formulations and mechanisms of action including retigabine for the treatment of epilepsy and pain taribavirin of the treatment of chronic hepatitis C and several dermatology candidates for the treatment of rosacea acne and dermatological fungus. Valeant Pharmaceuticals International Inc. is headquartered in Mississauga Canada.
SymbolCompanyMarket cap
SHPGShire Plc Ads$49.36 B
TKPYYTakeda Pharma$31.68 B
ALPMYAstellas Pharma Inc$28.78 B
ZTSZoetis Inc Class A Common Stoc$25.52 B
ESALYEisai Co Ltd Spons A$16.63 B
GRFSGrifols S.A.$10.13 B
TSROTesaro Inc$7.03 B
JAZZJazz Pharma Plc$6.1 B
IONSIonis Pharmaceutical$5.64 B
UTHRUnited Therapeutic$5.59 B

VRX Earnings

1st Quarter Earnings$1.55 (2016-11-08)
2nd Quarter Earnings$1.4 (2016-08-09)
3rd Quarter Earnings$1.27 (2016-06-07)
4th Quarter Earnings$2.5 (2016-03-15)
PE Ratio2.29
EPS Growth-32.16%
Recent Earnings$1.55
Annual EPS$6.73
Market Capitalization$5.37 B
Insider Shareholder %0.1637%
Annual Revenue$10.01 B
Number of Shares Outstanding347,540 Shares
Institutional Shareholder %66.21%
Annual Net Income$-2.23B
TTM Net Profit Margin$-22.55
One Year Return-83.39%
Three Year Return-97.82%
Five Year Return-66.54%
Five Year Revenue Growth784.37%
Five Year Earnings Growth541.27%
Five Year Dividend Growth-100%
Last Quarter EPS$1.55
Annual EPS$6.73
Annual Dividend$0
Annual Dividend Yield0%
Change in EPS YTD-32.16%
PE Ratio2.29
Recent Earnings$1.55
Dividends per Share$1
Stock Split Ratio2-1

VRX Key Stats

Last Price$15.46
Net Change$0.02 (0.13%)
Ask Price$0
Open Price$15.44
Previous Close Price$15.44
High Price$15.89
Low Price$15.35
Number of Trades26,421
Fifty Two Week High$119.87 (2015-12-16)
Fifty Two Week Low$13.77 (2016-11-08)
Average Daily Volume23,961,119
Share Outstanding347,540 Shares
Total Dividend Payout$0/yr
Dividend Yield0%